돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1517229생성일: 2026년 10월 26일

Zantac → Ranitidine docusate

https://huagongshe.com/reaction/1517229

반응식

참여 물질

역할이름HCID투입량
반응물ZantacHCID 47909—
반응물Sodium docusateHCID 9955175—
용매WaterHCID 962—
생성물Ranitidine docusateHCID 86612077—

반응 조건

온도60 °C

반응 단계

In a reaction vessel charged with a magnetic stirbar, 2.50 g (7.12 mmol) of Ranitidine hydrochloride was dissolved in approximately 25 mL of deionized water. In a separate reaction vessel, similarly charged with a stirbar, 3.17 g (7.12 mmol) of sodium docusate was dissolved/suspended in 25 mL of warm, deionized water. To the latter solution was added in one portion the aqueous solution of sodium docusate. The deep orange-brown milieu was stirred overnight, after which time the aqueous system was repeatedly extracted with 100 mL portions of chloroform. Emulsification of the two phases was quite pronounced, so each time the system was heated to about 60 ° C., then allowed to cool and settle for 5-7 days, after which point the dark chloroform phase was separated, dried over anhydrous MgSO4, filtered, and rotary evaporated to yield a viscous, deep brown-orange oil (Ranitidine docusate). The two ions have known histamine H2-receptor antagonist and an emollient properties, respectively.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08232265B2
출처 데이터셋uspto-grants-2012_07
ORD IDord-026e434cc59549f7a12f47eb03522313
출처 메모uspto-grants-2012_07